Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gerosa

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|August 28, 2019
Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune DiseasesChiara Bellocchi, Álvaro Fernández-Ochoa, Gaia Montanelli, et al.
Clinical and Experimental Rheumatology|May 24, 2023
Insights into the clinical presentation of juvenile systemic lupus erythematosus: the PRAGMA monocentric cohort of 177 patientsCecilia B Chighizola, Antonella Petaccia, Maurizio Gattinara, et al.
Journal of Nephrology|May 29, 2020
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow upLorenza Maria Argolini, Giulia Frontini, Elena Elefante, et al.
Biomolecules|September 28, 2023
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control StudyGiuseppe A Ramirez, Maria Gerosa, Chiara Bellocchi, et al.
RMD Open|February 8, 2022
Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccinationPaola Adele Lonati, Caterina Bodio, Mariangela Scavone, et al.
Arthritis Research & Therapy|July 11, 2014
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot studyPaolo Fraticelli, Barbara Gabrielli, Giovanni Pomponio, et al.
The Journal of Experimental Medicine|January 19, 2019
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosusCaterina E Faliti, Roberta Gualtierotti, Elsa Rottoli, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2020
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closureVittorio Pengo, Ariela Hoxha, Laura Andreoli, et al.
Frontiers in Immunology|September 3, 2019
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 PregnanciesMaria-Grazia Lazzaroni, Micaela Fredi, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|October 21, 2014
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'Mirko Scarsi, Antonella Radice, Francesca Pregnolato, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|August 28, 2019
Identification of a Shared Microbiomic and Metabolomic Profile in Systemic Autoimmune DiseasesChiara Bellocchi, Álvaro Fernández-Ochoa, Gaia Montanelli, et al.
Clinical and Experimental Rheumatology|May 24, 2023
Insights into the clinical presentation of juvenile systemic lupus erythematosus: the PRAGMA monocentric cohort of 177 patientsCecilia B Chighizola, Antonella Petaccia, Maurizio Gattinara, et al.
Journal of Nephrology|May 29, 2020
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow upLorenza Maria Argolini, Giulia Frontini, Elena Elefante, et al.
Biomolecules|September 28, 2023
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control StudyGiuseppe A Ramirez, Maria Gerosa, Chiara Bellocchi, et al.
RMD Open|February 8, 2022
Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccinationPaola Adele Lonati, Caterina Bodio, Mariangela Scavone, et al.
Arthritis Research & Therapy|July 11, 2014
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot studyPaolo Fraticelli, Barbara Gabrielli, Giovanni Pomponio, et al.
The Journal of Experimental Medicine|January 19, 2019
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosusCaterina E Faliti, Roberta Gualtierotti, Elsa Rottoli, et al.
Journal of Thrombosis and Haemostasis : JTH|October 31, 2020
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closureVittorio Pengo, Ariela Hoxha, Laura Andreoli, et al.
Frontiers in Immunology|September 3, 2019
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 PregnanciesMaria-Grazia Lazzaroni, Micaela Fredi, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|October 21, 2014
Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the 'Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group'Mirko Scarsi, Antonella Radice, Francesca Pregnolato, et al.
Pageof 12